[{"id":6496,"regimens":[{"id":12726,"duration":{"id":6697,"approximate_duration":"7 days","dates_unknown":true},"drug":{"id":8436,"name":"Infliximab","url":"cure-api2.ncats.io/v1/drugs/8436","rxNorm_id":null,"notes":null},"use_drug":[{"id":10719,"answer":"It was not used in a new way","answer_other":"","regimen":12726},{"id":10720,"answer":"Other","answer_other":"Was primarily given as rescue therapy for UC","regimen":12726}],"created":"2020-11-17T20:13:17.356226Z","updated":"2020-11-19T17:06:45.754201Z","dose":"5 mg/kg","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":6496},{"id":12757,"duration":null,"drug":{"id":9077,"name":"Methylprednisolone","url":"cure-api2.ncats.io/v1/drugs/9077","rxNorm_id":null,"notes":null},"use_drug":[{"id":10721,"answer":"It was not used in a new way","answer_other":"","regimen":12757},{"id":10722,"answer":"Other","answer_other":"Was primarily given for UC","regimen":12757}],"created":"2020-11-19T17:06:45.749798Z","updated":"2020-11-19T17:06:45.755149Z","dose":null,"frequency":"","route":"IV","severity":null,"severity_detail":null,"comments":null,"report":6496}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8542,"answer":"Clinical assessment","answer_other":"","report":6496},{"id":8543,"answer":"Imaging","answer_other":"","report":6496},{"id":8544,"answer":"PCR","answer_other":"","report":6496}],"how_diagnosis":[{"id":14613,"answer":"Clinical assessment","answer_other":"","report":6496},{"id":14614,"answer":"Imaging","answer_other":"","report":6496},{"id":14615,"answer":"PCR","answer_other":"","report":6496}],"author_username":"Cure Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Other Healthcare Professional","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4647,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6496}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[],"created":"2020-11-17T20:12:55.111685Z","updated":"2020-11-19T17:06:45.720400Z","title":"Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32554621,"doi":"10.1136/gutjnl-2020-321760","article_url":"https://pubmed.ncbi.nlm.nih.gov/32554621/","pub_year":2020,"published_authors":"Bezzio C\r\nManes G\r\nBini F\r\nPellegrini L\r\nSaibeni S","article_author_email":"Author email could not be found.","journal":"Gut","abstract":"No abstract available","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"1","full_text_available":true,"outcome":"Patient improved","surgery":"No","age":"31-40 years","sex":"Male","ethnicity":null,"country_contracted":"Italy","country_treated":"Italy","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"ulcerative colitis","pregnant":false,"unknown":false,"site_of_disease":"lungs","clinical_syndrome":"pneumonia, respiratory tract infection","severity":"Inpatient","prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"This patient was admitted for a severe recurrence of ulcerative colitis. They were taking mesalazine in both oral and topical formulations. This patient was administered low-molecular weight heparin and 5 days of IV methylprednisolone which improved the IBD. Following COVID-19 diagnosis, the steroid therapy was taper and moved to oral administration. The patient was discharged and completed a second infusion of infliximab and induction regimen.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[8436,9077]}]